IXUS vs. VYMI: Which International Stock ETF Is a Better Buy?

The article compares two international ETFs: IXUS, with 4,158 stocks and a 0.07% expense ratio, versus VYMI, with 1,597 stocks, a 0.07% expense ratio, a 3.47% dividend yield, and a lower P/E of 14.5 vs 18.1 for IXUS. VYMI has outperformed over the past five and 10 years, returning about 44% over five years and averaging 10.4% annual total returns over 10 years versus 30% and 9.3% for IXUS. The piece is mostly a valuation and strategy comparison, mildly favoring the dividend-focused ETF for long-term investors.

Analysis

The key signal here is not “international vs U.S.” but factor composition: VYMI is effectively a quality/value/cash-return tilt on non-U.S. equities, while IXUS is a broad beta sleeve. In a world where global rates have normalized and balance sheets matter again, that tilt should continue to screen better than plain-cap weighted exposure, especially because dividends outside the U.S. often proxy for mature franchises with less earnings dispersion and lower financing sensitivity. The likely second-order effect is that VYMI gets a structural tailwind from sectors that benefit when growth slows but nominal yields stay elevated—banks, insurers, staples, and energy—rather than from the AI-linked parts of the market.

That said, the crowding risk is hidden in the “cheap and high-yielding” narrative. If global growth reaccelerates or the U.S. dollar weakens sharply, IXUS should outperform because it has greater exposure to cyclicals, EM beta, and lower-quality rebound names that are currently underrepresented in dividend screens. Over a 6–18 month horizon, the biggest reversal catalyst for VYMI is a rotation back into duration-sensitive growth and non-dividend compounders, which would compress its relative advantage even if absolute returns remain fine.

From a second-order perspective, the article’s cited holdings imply VYMI is indirectly levered to capital returns discipline in Japan, Europe, and Canada. If those markets continue increasing payouts and buybacks, the ETF can sustain multiple support even without explosive top-line growth. The more interesting downside is that a dividend screen can become a value trap in ex-U.S. markets if payout ratios are being preserved by capex cuts or sluggish reinvestment; that would show up first in earnings quality rather than price action.

Key Decisions for Investors

• Overweight VYMI vs IXUS for a 6-12 month tactical sleeve: long VYMI / short IXUS in roughly 1:1 dollars to express the dividend-quality factor without taking net market beta; stop if global PMIs reaccelerate for 2 consecutive months.
• Buy VYMI on a 3-5% pullback and pair it with a short-dated hedge on EFA or VGK if you want to isolate developed-market dividend resilience; expected reward is modest absolute upside, but 150-250 bps of annualized relative outperformance if rates stay higher for longer.
• Use IXUS only as a broad diversification hedge, not a core alpha sleeve; if entering now, cap position size and avoid adding above recent highs because the fund’s appeal is mostly strategic, not timing-sensitive.
• For investors already long U.S. growth/AI, add VYMI as a diversifier rather than chasing emerging-market beta; this reduces single-factor concentration and should dampen drawdowns if AI leadership broadens only slowly.
• If you expect a U.S. dollar selloff over the next 3-9 months, prefer IXUS over VYMI for that leg, since broader currency and EM exposure should provide more upside convexity than the dividend screen.